TotalMarketCap

Anaptysbio

ANABNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.351 B

$45.63 -3.96%

Close of 6 Nov 2026

As of 6 Nov 2026, Anaptysbio (ANAB) has a market capitalization of $1.35B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$234.6M

#2224 by revenue

Earnings

-$13.2M

Loss-making

Shares outstanding

29,895,244

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #126Damora TherapeuticsDMRA$1.35B
  2. #127Mineralys TherapeuticsMLYS$1.35B
  3. #128AnaptysbioANAB$1.35B
  4. #129Eton PharmaceuticalsETON$1.35B
  5. #130KardiganKARD$1.30B

What if Anaptysbio were worth as much as…

Open the what-if tool →

Gold $28.2T

$953,675.19

Per share 20,900× higher

Bitcoin $1.53T

$51,601.70

Per share 1,131× higher

Apple $5.02T

$169,403.58

Per share 3,713× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Anaptysbio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.